MTOR and graft versus host disease: The mTOR enzyme induces metabolic reprogramming of alloantigen activated T-cells after allogeneic hematopoietic stem cell transplantation, which utilizes the glycolytic pathway to sustain alloreactive T cells mediated graft versus host disease (GvHD) (174, 175).